clopidogrel has been researched along with Hemorrhagic Shock in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aubert, J; Delalande, JP; Skowronski, P | 1 |
Banerjee, A; Fragoso, M; Gamboni, F; Harr, JN; Jones, WL; Moore, EE; Silliman, CC; Stringham, J; Wohlauer, MV | 1 |
2 other study(ies) available for clopidogrel and Hemorrhagic Shock
Article | Year |
---|---|
[Aneurysm of abdominal aorta rupture in a patient on dabigatran treatment].
Topics: Aged; Antithrombins; Aortic Aneurysm, Abdominal; Aortic Rupture; Arrhythmias, Cardiac; Aspirin; Benzimidazoles; beta-Alanine; Blood Transfusion, Autologous; Clopidogrel; Dabigatran; Humans; Male; Plasma; Platelet Aggregation Inhibitors; Platelet Transfusion; Shock, Hemorrhagic; Ticlopidine | 2013 |
Isoflurane prevents acute lung injury through ADP-mediated platelet inhibition.
Topics: Acute Lung Injury; Anesthetics, Inhalation; Animals; Blood Platelets; Clopidogrel; Fluorescent Antibody Technique; Isoflurane; Lung; Male; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Resuscitation; Shock, Hemorrhagic; Ticlopidine | 2012 |